Work

Is it reasonable to administer pegfilgrastim on day 1 of a myelosuppressive chemotherapy regimen? A cost-utility analysis

Year: 2013

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2013.04.201

Authors: C. Billingsley, D. Cohn, A. Crim, D. O’Malley, L. Havrilesky

Institutions: The Ohio State University, Duke Medical Center

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2063029038

FWCI:

Cites:

Cited by:

Related to: 10